Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Galaxy MedicareNSE:GML 20 Earnings Yield (Joel Greenblatt) % is 31.25% as of Mar. 2026, which is 85% above its 10-year median of 16.87. GuruFocus rates NSE:GML with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 848 Medical Devices & Instruments companies, Galaxy Medicare ranks better than 97.29% on this metric.
Galaxy Medicare's Enterprise Value for the quarter that ended in Mar. 2026 was ₹159.6 Mil.
Galaxy Medicare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹49.8 Mil. Galaxy Medicare's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 31.25%.
The historical rank and industry rank for Galaxy Medicare's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NSE:GML'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 6.9 Med: 16.87 Max: 30.52
Current: 26.32
During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of Galaxy Medicare was 30.52%. The lowest was 6.90%. And the median was 16.87%.
NSE:GML's Earnings Yield (Joel Greenblatt) % is ranked better than 97.29% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 1.14
vs NSE:GML: 26.32
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Galaxy Medicare's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Galaxy Medicare Earnings Yield (Joel Greenblatt) % Related Terms
Galaxy Medicare Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Galaxy Medicare's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Galaxy Medicare's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galaxy Medicare Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Galaxy Medicare's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Galaxy Medicares Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2026 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 31.25% mean?
Galaxy Medicare (NSE:GML) has a Earnings Yield (Joel Greenblatt) % of 31.25% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Galaxy Medicare and its competitors. This is 85% above median its historical median of 16.87. Over the past decade, Galaxy Medicare's Earnings Yield (Joel Greenblatt) % has ranged from 6.90 to 30.52. According to the industry distribution chart, Galaxy Medicare ranks #23 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 2.7%.
Is Galaxy Medicare's Earnings Yield (Joel Greenblatt) % too high?
Galaxy Medicare's current Earnings Yield (Joel Greenblatt) % of 31.25% is 85% above median its 10-year median of 16.87. Over the past 10 years, this metric has ranged from a low of 6.90 to a high of 30.52. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 1.14. Galaxy Medicare's value of 31.25% is 2641.2% above this industry median. Based on the distribution chart, Galaxy Medicare ranks #23 out of 848 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Galaxy Medicare has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's Earnings Yield (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Galaxy Medicare ranks #23 out of 848 companies for Earnings Yield (Joel Greenblatt) %. This places Galaxy Medicare in the top 3% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 1.14. Galaxy Medicare's value of 31.25% is 2641.2% above this benchmark. Historically, Galaxy Medicare's own Earnings Yield (Joel Greenblatt) % has ranged from 6.90 to 30.52 over the past decade. While the company's 10-year median is 16.87 vs. the industry median of 1.14, Galaxy Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 1.14, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galaxy Medicare's current Earnings Yield (Joel Greenblatt) % of 31.25% is 2641.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Galaxy Medicare and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galaxy Medicare's current Earnings Yield (Joel Greenblatt) % is 31.25%, which is 85% above median its own 10-year median of 16.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current Earnings Yield (Joel Greenblatt) % of 31.25%. The current Earnings Yield (Joel Greenblatt) % is 31.25%, which is 85% above median its 10-year median of 16.87 and 2641.2% above the Medical Devices & Instruments industry median of 1.14. Galaxy Medicare's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current Earnings Yield (Joel Greenblatt) % is 31.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
20GF Score
Get the complete analysis for NSE:GML
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GML has been successfully added to your 
